← Leaderboards
Chuan-Yuan Li
Duke University
$14,248,346
Attributed
$14,248,346
Total exposure
11
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.5M · FY2005–22$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$14,248,346 · 11
By mechanism
R01$13,283,387 · 9
R21$498,329 · 1
P30$466,630 · 1
Top collaborators
No co-investigators on record.
Most similar at Duke University
Same institution · by research overlap
- Edward A Miao$16,675,058
- Darell D Bigner$25,397,506
- Kris C. Wood$5,294,947
- Rahima Zennadi$5,222,881
- Scott J Antonia$4,663,305
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseMediatingMolecularNeoplastic CellPlayGeneticTumorInsightCancer TherapyRadiation TherapyMalignant NeoplasmsResponseBiologicalIn VivoKnock-OutCellsPathway InteractionsCancer Radiation TherapySmall Hairpin RnaGenesApoptosisHypoxiaRadiationIn Vitro
Grant awards (46)
Novel roles of PCSK9 in regulating the tumor immune microenvironment during radiotherapy$535,077
R01 · FY2022 · CA · contact PI
Targeting ATM to boost systemic effects of radiotherapy and immunotherapy$516,032
R01 · FY2022 · CA · contact PI
Targeting ATM to boost systemic effects of radiotherapy and immunotherapy$526,563
R01 · FY2021 · CA · contact PI
Targeting apoptotic caspases to enhance cancer radiotherapy$467,757
R01 · FY2021 · CA · contact PI
Targeting apoptotic caspases to enhance cancer radiotherapy$467,757
R01 · FY2020 · CA · contact PI
Necroptotic genes in cancer cellular response to radiation$443,001
R01 · FY2020 · CA · contact PI
Targeting apoptotic caspases to enhance cancer radiotherapy$452,079
R01 · FY2019 · CA · contact PI
Necroptotic genes in cancer cellular response to radiation$429,710
R01 · FY2019 · CA · contact PI
Targeting apoptotic caspases to enhance cancer radiotherapy$463,156
R01 · FY2018 · CA · contact PI
Necroptotic genes in cancer cellular response to radiation$443,001
R01 · FY2018 · CA · contact PI
Pro-oncogenic roles of apoptotic caspases$357,750
R01 · FY2018 · ES · contact PI
Necroptotic genes in cancer cellular response to radiation$443,001
R01 · FY2017 · CA · contact PI
Pro-oncogenic roles of apoptotic caspases$357,750
R01 · FY2017 · ES · contact PI
Pro-oncogenic roles of apoptotic caspases$357,750
R01 · FY2016 · ES · contact PI
Pro-oncogenic roles of apoptotic caspases$356,250
R01 · FY2015 · ES · contact PI
The "Phoenix Rising" pathway of tumor repopulation during radiotherapy$325,775
R01 · FY2015 · CA · contact PI
Cell and Gene Modification Core$234,668
P30 · FY2015 · AR · contact PI
Pro-oncogenic roles of apoptotic caspases$353,250
R01 · FY2014 · ES · contact PI
The "Phoenix Rising" pathway of tumor repopulation during radiotherapy$316,002
R01 · FY2014 · CA · contact PI
Molecular mechanisms of tumor response to cytotoxic chemotherapy$288,130
R01 · FY2014 · CA · contact PI
HIF genes in head and neck cancer radiotherapy$288,130
R01 · FY2014 · CA · contact PI
Cell and Gene Modification Core$231,962
P30 · FY2014 · AR · contact PI
The "Phoenix Rising" pathway of tumor repopulation during radiotherapy$306,229
R01 · FY2013 · CA · contact PI
Molecular mechanisms of tumor response to cytotoxic chemotherapy$1
R01 · FY2013 · CA · contact PI
HIF genes in head and neck cancer radiotherapy$1
R01 · FY2013 · CA · contact PI
The "Phoenix Rising" pathway of tumor repopulation during radiotherapy$325,775
R01 · FY2012 · CA · contact PI
Molecular mechanisms of tumor response to cytotoxic chemotherapy$316,002
R01 · FY2012 · CA · contact PI
HIF genes in head and neck cancer radiotherapy$316,002
R01 · FY2012 · CA · contact PI
The "Phoenix Rising" pathway of tumor repopulation during radiotherapy$325,775
R01 · FY2011 · CA · contact PI
Molecular mechanisms of tumor response to cytotoxic chemotherapy$302,518
R01 · FY2011 · CA · contact PI
HIF genes in head and neck cancer radiotherapy$300,270
R01 · FY2011 · CA · contact PI
Molecular mechanisms of tumor response to cytotoxic chemotherapy$312,203
R01 · FY2010 · CA · contact PI
HIF genes in head and neck cancer radiotherapy$310,038
R01 · FY2010 · CA · contact PI
Molecular mechanisms of tumor response to cytotoxic chemotherapy$313,266
R01 · FY2009 · CA · contact PI
HIF genes in head and neck cancer radiotherapy$310,841
R01 · FY2009 · CA · contact PI
Hyperthermia-mediated gene therapy approach for cancer$219,030
R01 · FY2007 · CA · contact PI
Hyperthermia-mediated gene therapy approach for cancer$225,572
R01 · FY2006 · CA · contact PI
Hyperthermia-mediated gene therapy approach for cancer$231,000
R01 · FY2005 · CA
Hyperthermia-mediated gene therapy approach for cancer$231,000
R01 · FY2004 · CA
Imaging Tumor Hypoxia in a Transgenic Mouse Model$152,290
R21 · FY2004 · EB
Imaging Tumor Hypoxia in a Transgenic Mouse Model$115,039
R21 · FY2004 · EB
Hyperthermia-mediated gene therapy approach for cancer$231,000
R01 · FY2003 · CA
Imaging Tumor Hypoxia in a Transgenic Mouse Model$231,000
R21 · FY2003 · EB
HYPERTHERMIA MEDIATED GENE THERAPY APPROACH FOR CANCER$177,799
R01 · FY2002 · CA
HYPERTHERMIA MEDIATED GENE THERAPY APPROACH FOR CANCER$172,934
R01 · FY2001 · CA
HYPERTHERMIA MEDIATED GENE THERAPY APPROACH FOR CANCER$168,210
R01 · FY2000 · CA